Vanguard Portfolio Management
PFE icon

Vanguard Portfolio Management’s Pfizer PFE Stock Holding History

Vanguard Portfolio Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87B Buy
119,235,030
+2,500,335
+2% +$65.4M 0.13% 143
2026
Q1 		$3.28B Buy
+116,734,695
New +$3.11B 0.17% 101

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Portfolio Management's PFE Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Pfizer (PFE) stake by 2.1% in Q2 2026, buying an estimated $65.4M and bringing the position to 119,235,030 shares worth $2.87B. The position accounts for 0.13% of the portfolio, ranked #143.

Vanguard Portfolio Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.28B in Q1 2026. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vanguard Portfolio Management held 119,235,030 shares of Pfizer worth $2.87B as of Q2 2026.
  • Vanguard Portfolio Management bought 2,500,335 Pfizer shares in Q2 2026, an estimated $65.4M.
  • Pfizer made up 0.13% of Vanguard Portfolio Management's portfolio in Q2 2026, its #143 holding.
  • Vanguard Portfolio Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Pfizer position peaked at $3.28B in Q1 2026.
  • 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.